搜索结果
ID | 拉丁名 | 药名 | 药用植物名 | 功能与主治 | 来源 | 药用部位 | 使用民族 |
---|
化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
---|
TCMBANKIN058519 | (-)-epigallocatechin-3-gallate; (-)-epigallocatechin 3-o-gallate;epigallocatechin gallate; galloyl-l-epigallocatechol; epigallocatechin 3-gallate; (-)-epigallocatechin gallate; | KBio2_000796; SpecPlus_000277; 50299_FLUKA; Spectrum3_000244; KBioGR_002002; 3,4,5-trihydroxybenzoic acid [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] ester; MLS000758300; DivK1c_006373; (−)-Epigallocatechin gallate; EGCG; SPBio_000035; (−)-cis-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-gallate; KBioSS_000796; Epigallocatechin gallate; Spectrum4_001541; (-)-epigallocatechin 3-gallate; Tea catechin; AIDS000674; KBio2_005932; 3,4,5-trihydroxybenzoic acid [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3-chromanyl] ester; KBio1_001317; 989-51-5; AIDS-000674; (2R,3R)-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1[2H]-benzopyran-3,5,7-triol-3-(3,4,5-trihydroxybenzoate); KBio2_003364; Galloyl-L-epigallocatechol; SDCCGMLS-0066550.P001; (-)-Epigallocatechol gallate; ACon1_001054; Spectrum5_000102; Green tea extract; MEGxp0_001166; C09731; (-)-Epigallocatechin-3-o-gallate; Epigallocatechin 3-gallate; (-)-Epigallocatechin gallate; CCRIS 3729; Teavigo; [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] 3,4,5-trihydroxybenzoate; Spectrum2_000168; Benzoic acid, 3,4,5-trihydroxy-, (2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester; (−)-cis-3,3′,4′,5,5′,7-Hexahydroxy-flavane-3-gallate; CHEBI:4806; (-)-epigallocatechin-3-gallate ; (-)-Epigallocatechin gallate (85% (-)-epigallocatechin gallate, 10% (-)-epigallocatechin, 5% (-)- epicatechin gallate); Catechin deriv.; SMR000449288; SPECTRUM210239; E4143_SIAL; (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate; Spectrum_000316; (-)-EGCG; KBio3_001128; BSPBio_001628; Epigallocatechol, 3-gallate, (-)-; Epigallocatechin-3-gallate; E4268_SIAL; epigallocatechin gallate ; epigallocatechin-3-gallate; (-)epigallocatechin-3-gallate ; EGCG; 989E515; [5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] 2,3,4-trihydroxybenzoate; HMS2051K21; CS-1258; AC1L22IG; AK165605; Green tea polyphenols, Anagen; (-)-Epigallocatechin-3-O-gallate, United States Pharmacopeia (USP) Reference Standard; AKOS015918182; CAS-989-51-5; Epigallocatechin gallate, primary pharmaceutical reference standard; W-5069; (-)-cis-3,3',4',5,5',7-Hexahydroxy-flavane-3-gallate; (-)-Epigallocatechin gallate, analytical standard; Q-100914; DSSTox_RID_78830; AN-15867; DSSTox_GSID_29889; (-)-Epigallocatechol gallate; FT-0604392; NCGC00164319-04; Green tea extract; MEGxp0_001166; (-)-Epigallocatechin-3-o-gallate; Epigallocatechin 3-gallate; N1874; CHEBI:4806; (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate; BG00814299; HMS3649E08; D0E9DB; Epigallocatechol, 3-gallate, (-)-; (-)-EpigallocatechinGallateHydrate; Epigallocatechin-3-gallate; AB0014381; BQM438CTEL; NC00078; ST51055716; Epigallocatechin gallate, Pharmaceutical Secondary Standard; Certified Reference Material; SpecPlus_000277; Spectrum3_000244; (2R,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl-3,4,5-trihydroxybenzoate; MLS000758300; (-)-Epigallocatechin gallate (EGCG); CCG-38378; Gallic acid, 3-ester with epigallocatechol, (-)-; SR-01000946601-1; NCGC00164319-01; (-)-cis-3,4-Dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-1(2H)-benzopyran-3-yl Gallate; NCGC00164319-06; DSSTox_CID_567; MCULE-3341525983; Epigallocatechin monogallate, B; Tox21_303457; SAM001247031; 4awm; K791; 989-51-5; SR-01000946601; MFCD00075940; EGCG analogs; Galloyl-L-epigallocatechol; NCGC00164319-03; (-)-Epigallocatechin gallate, >=80% (HPLC), from green tea; Spectrum5_000102; CPD000449288; (-)-Epigallocatechin gallate; LMPK12030005; E0694; Teavigo; Epigallocatechin gallate analogs, Anagen; Epigallocatechin-3-monogallate; ACN-035233; Benzoic acid, 3,4,5-trihydroxy-, (2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester; Sunphenon; Epigallocatechin gallate(EGCG); s2250; PF-EGCg 90; 3,4-Dihydro-5,7-dihydroxy-2R-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3R-yl-3,4,5-trihydroxybenzoate; 3,4,5-Trihydroxybenzoic acid (2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester; MLS001424000; (-)-EGCG; ZINC3870412; KBio2_000796; EGCG cpd; KBioGR_002002; Benzoic acid, 3,4,5-trihydroxy-, 3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester, (2R-cis)-; EGCG, Anagen; NCGC00257243-01; Tox21_201468; L-Epigallocatechin gallate; cid_65064; SPBio_000035; BG01747388; Epigallocatechin gallate; KBioSS_000796; Spectrum4_001541; (-)-epigallocatechin 3-gallate; DB12116; EPIGALOCATECHIN GALLATE; ANTIOXIDANT MODEL (TRAMP) -EPIGALLOCATECHIN GALLATE; KBio2_005932; I14-7747; D0U2BH; MCULE-7760530136; 2kdh; Epigallocatechin gallate, Anagen; AOB2839; SDCCGMLS-0066550.P001; 863-65-0; FR-109; ST097428; ACon1_001054; LS-2197; CCRIS 3729; [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] 3,4,5-trihydroxybenzoate; Epigallocate; GTPL7002; BDBM50070942; C22H18O11; GTPs,Anagen; SCHEMBL35258; (2R,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl 3,4,5-trihydroxybenzoate; MolPort-001-741-358; DivK1c_006373; KB-206444; SR-01000759328; Teavigo;; EGCG; (-)-EPIGALLOCATECHIN GALLATE (GREEN TEA EXTRACT); HY-13653; (-)-Epigallocatechin gallate, >=95%; NCGC00259019-01; Tea catechin; DS-9030; SR-01000759328-6; SR-01000759328-5; KDH; AC1Q5X0Z; KBio1_001317; (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl 3,4,5-trihydroxyb enzoate; (2R,3R)-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1[2H]-benzopyran-3,5,7-triol-3-(3,4,5-trihydroxybenzoate); NVP-XAA 723; KBio2_003364; EBD2138593; FT-0082796; NCGC00164319-02; C09731; (-)-cis-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-gallate; UNII-BQM438CTEL; DTXSID1029889; WMBWREPUVVBILR-WIYYLYMNSA-N; [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate; (-)-Epigallocatehin gallate; Spectrum2_000168; (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate; (-)-Epigallocatechin gallate (85% (-)-epigallocatechin gallate, 10% (-)-epigallocatechin, 5% (-)- epicatechin gallate); Catechin deriv.; SMR000449288; (-)-Epigallocatechin gallat; SPECTRUM210239; Epigallocic acid; Epigallocatcchin Gallate; KS-0000132O; BP-30205; CHEMBL297453; SC-47284; Spectrum_000316; 3oob; (-)-Epigallocatechin gallate, >=97.0% (HPLC); KBio3_001128; BSPBio_001628; epigallo-catechin gallate | C22H18O11 | 458.4g/mol | C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O |
靶点ID | 基因名 | 基因别名 | 描述 |
---|
TCMBANKGE013564 | PYY | PYY-I; PYY1 | peptide YY |
TCMBANKGE014645 | SI | - | sucrase-isomaltase |
TCMBANKGE001180 | SMAD3 | HSPC193; HsT17436; JV15-2; LDS1C; LDS3; MADH3 | SMAD family member 3 |
TCMBANKGE009389 | LYZ | LYZF1; LZM | lysozyme |
TCMBANKGE000452 | CFTR | ABC35; ABCC7; CF; CFTR/MRP; MRP7; TNR-CFTR; dJ760C5.1 | CF transmembrane conductance regulator |
TCMBANKGE000583 | MIR22 | MIRN22; hsa-mir-22; miR-22 | microRNA 22 |
TCMBANKGE001132 | BAX | BCL2L4 | BCL2 associated X, apoptosis regulator |
TCMBANKGE000029 | GZMB | C11; CCPI; CGL-1; CGL1; CSP-B; CSPB; CTLA1; CTSGL1; HLP; SECT | granzyme B |
TCMBANKGE000742 | SMAD7 | CRCS3; MADH7; MADH8 | SMAD family member 7 |
TCMBANKGE000430 | LRRK2 | AURA17; DARDARIN; PARK8; RIPK7; ROCO2 | leucine rich repeat kinase 2 |
TCMBANKGE011654 | NPS | - | neuropeptide S |
TCMBANKGE014282 | ID2 | GIG8; ID2A; ID2H; bHLHb26 | inhibitor of DNA binding 2 |
TCMBANKGE003099 | CD163 | M130; MM130; SCARI1 | CD163 molecule |
TCMBANKGE014946 | ALK | CD246; NBLST3 | ALK receptor tyrosine kinase |
TCMBANKGE010716 | AMBP | A1M; EDC1; HCP; HI30; IATIL; ITI; ITIL; ITILC; UTI | alpha-1-microglobulin/bikunin precursor |
TCMBANKGE013010 | COX2 | COII; MTCO2 | cytochrome c oxidase subunit II |
TCMBANKGE001076 | SOD2 | GClnc1; IPO-B; IPOB; MNSOD; MVCD6; Mn-SOD | superoxide dismutase 2 |
TCMBANKGE000316 | IL5 | EDF; IL-5; TRF | interleukin 5 |
TCMBANKGE000903 | PTGS1 | COX1; COX3; PCOX1; PES-1; PGG/HS; PGHS-1; PGHS1; PHS1; PTGHS | prostaglandin-endoperoxide synthase 1 |
TCMBANKGE001052 | NLRP3 | AGTAVPRL; AII; AVP; C1orf7; CIAS1; CLR1.1; DFNA34; FCAS; FCAS1; FCU; KEFH; MWS; NALP3; PYPAF1 | NLR family pyrin domain containing 3 |
TCMBANKGE009679 | BTD | - | biotinidase |
TCMBANKGE006489 | P2RY1 | P2Y1; SARCC | purinergic receptor P2Y1 |
TCMBANKGE010505 | LRBA | BGL; CDC4L; CVID8; LAB300; LBA | LPS responsive beige-like anchor protein |
TCMBANKGE006656 | B2M | IMD43 | beta-2-microglobulin |
TCMBANKGE000994 | AKR1B1 | ADR; ALDR1; ALR2; AR | aldo-keto reductase family 1 member B |
TCMBANKGE011702 | TNFRSF8 | CD30; D1S166E; Ki-1 | TNF receptor superfamily member 8 |
TCMBANKGE011283 | LRRC8D | LRRC5 | leucine rich repeat containing 8 VRAC subunit D |
TCMBANKGE000230 | ADIPOQ | ACDC; ACRP30; ADIPQTL1; ADPN; APM-1; APM1; GBP28 | adiponectin, C1Q and collagen domain containing |
TCMBANKGE000720 | KRT1 | CK1; EHK; EHK1; EPPK; K1; KRT1A; NEPPK | keratin 1 |
TCMBANKGE001897 | SLC10A2 | ASBT; IBAT; ISBT; NTCP2; PBAM | solute carrier family 10 member 2 |
TCMBANKGE014555 | P2RX1 | P2X1 | purinergic receptor P2X 1 |
TCMBANKGE000060 | CRHR1 | CRF-R; CRF-R-1; CRF-R1; CRF1; CRFR-1; CRFR1; CRH-R-1; CRH-R1; CRHR; CRHR1L | corticotropin releasing hormone receptor 1 |
TCMBANKGE006649 | ANO1 | DOG1; ORAOV2; TAOS2; TMEM16A | anoctamin 1 |
TCMBANKGE001801 | ALG8 | CDG1H; PCLD3 | ALG8 alpha-1,3-glucosyltransferase |
TCMBANKGE004355 | EHMT1 | EHMT1-IT1; EUHMTASE1; Eu-HMTase1; FP13812; GLP; GLP1; KLEFS1; KMT1D | euchromatic histone lysine methyltransferase 1 |
TCMBANKGE005349 | P2RX3 | P2X3 | purinergic receptor P2X 3 |
TCMBANKGE000853 | FFAR2 | FFA2R; GPR43 | free fatty acid receptor 2 |
TCMBANKGE000205 | NOS2 | HEP-NOS; INOS; NOS; NOS2A | nitric oxide synthase 2 |
TCMBANKGE013424 | LCT | LAC; LPH; LPH1 | lactase |
TCMBANKGE000028 | PHB | HEL-215; HEL-S-54e; PHB1 | prohibitin |
TCMBANKGE000298 | SOD1 | ALS; ALS1; HEL-S-44; IPOA; SOD; STAHP; hSod1; homodimer | superoxide dismutase 1 |
TCMBANKGE001156 | CASP3 | CPP32; CPP32B; SCA-1 | caspase 3 |
TCMBANKGE006748 | IL16 | LCF; NIL16; PRIL16; prIL-16 | interleukin 16 |
TCMBANKGE014979 | NOD2 | ACUG; BLAU; BLAUS; CARD15; CD; CLR16.3; IBD1; NLRC2; NOD2B; PSORAS1; YAOS | nucleotide binding oligomerization domain containing 2 |
TCMBANKGE012773 | MIF | GIF; GLIF; MMIF | macrophage migration inhibitory factor |
TCMBANKGE001048 | TGM2 | TG(C); TGC | transglutaminase 2 |
TCMBANKGE000882 | SERPINE1 | PAI; PAI-1; PAI1; PLANH1 | serpin family E member 1 |
TCMBANKGE006957 | SLC16A4 | MCT4; MCT5 | solute carrier family 16 member 4 |
TCMBANKGE008068 | PRTN3 | ACPA; AGP7; C-ANCA; CANCA; MBN; MBT; NP-4; NP4; P29; PR-3; PR3 | proteinase 3 |
TCMBANKGE000757 | PTPN2 | PTN2; PTPT; TC-PTP; TCELLPTP; TCPTP | protein tyrosine phosphatase non-receptor type 2 |
TCMBANKGE001179 | SMAD2 | JV18; JV18-1; MADH2; MADR2; hMAD-2; hSMAD2 | SMAD family member 2 |
TCMBANKGE009540 | ITGB4 | CD104; GP150 | integrin subunit beta 4 |
TCMBANKGE013738 | LTBR | D12S370; LT-BETA-R; TNF-R-III; TNFCR; TNFR-RP; TNFR2-RP; TNFR3; TNFRSF3 | lymphotoxin beta receptor |
TCMBANKGE006959 | SLC16A3 | MCT 3; MCT 4; MCT-3; MCT-4; MCT3; MCT4 | solute carrier family 16 member 3 |
TCMBANKGE002129 | SELENOP | SELP; SEPP; SEPP1; SeP | selenoprotein P |
TCMBANKGE014355 | DAPK3 | DLK; ZIP; ZIPK | death associated protein kinase 3 |
TCMBANKGE001069 | MPO | - | myeloperoxidase |
TCMBANKGE003071 | P2RY2 | HP2U; P2RU1; P2U; P2U1; P2UR; P2Y2; P2Y2R | purinergic receptor P2Y2 |
TCMBANKGE000218 | P2RX2 | DFNA41; P2X2 | purinergic receptor P2X 2 |
TCMBANKGE005030 | STX3 | STX3A | syntaxin 3 |
TCMBANKGE005922 | LPIN2 | - | lipin 2 |
TCMBANKGE011131 | RAB11A | YL8 | RAB11A, member RAS oncogene family |
TCMBANKGE001161 | IL2 | IL-2; TCGF; lymphokine | interleukin 2 |
TCMBANKGE006718 | AIRE | AIRE1; APECED; APS1; APSI; PGA1 | autoimmune regulator |
TCMBANKGE013600 | DEFB4A | BD-2; DEFB-2; DEFB102; DEFB2; DEFB4; HBD-2; SAP1 | defensin beta 4A |
TCMBANKGE001178 | STAT3 | ADMIO; ADMIO1; APRF; HIES | signal transducer and activator of transcription 3 |
TCMBANKGE011371 | REG4 | GISP; REG-IV; RELP | regenerating family member 4 |
TCMBANKGE015151 | HPGDS | GSTS; GSTS1; GSTS1-1; PGD2; PGDS | hematopoietic prostaglandin D synthase |
TCMBANKGE005131 | ALDH1A2 | RALDH(II); RALDH2; RALDH2-T | aldehyde dehydrogenase 1 family member A2 |
TCMBANKGE013026 | HSPD1 | CPN60; GROEL; HLD4; HSP-60; HSP60; HSP65; HuCHA60; SPG13 | heat shock protein family D (Hsp60) member 1 |
TCMBANKGE000432 | ADAM17 | ADAM18; CD156B; CSVP; NISBD; NISBD1; TACE | ADAM metallopeptidase domain 17 |
TCMBANKGE008721 | SLCO2A1 | MATR1; OATP2A1; PGT; PHOAR2; SLC21A2 | solute carrier organic anion transporter family member 2A1 |
TCMBANKGE001073 | PTGS2 | COX-2; COX2; GRIPGHS; PGG/HS; PGHS-2; PHS-2; hCox-2 | prostaglandin-endoperoxide synthase 2 |
TCMBANKGE012204 | ACAD8 | ACAD-8; ARC42; IBDH | acyl-CoA dehydrogenase family member 8 |
TCMBANKGE010973 | EPCAM | DIAR5; EGP-2; EGP314; EGP40; ESA; HNPCC8; KS1/4; KSA; M4S1; MIC18; MK-1; TACSTD1; TROP1 | epithelial cell adhesion molecule |
TCMBANKGE000224 | AGT | ANHU; SERPINA8; hFLT1 | angiotensinogen |
TCMBANKGE001113 | ACTA2 | ACTSA | actin alpha 2, smooth muscle |
TCMBANKGE011129 | GH1 | GH; GH-N; GHB5; GHN; IGHD1A; IGHD1B; IGHD2; hGH-N | growth hormone 1 |
TCMBANKGE000163 | TNFRSF1B | CD120b; TBPII; TNF-R-II; TNF-R75; TNFBR; TNFR1B; TNFR2; TNFR80; p75; p75TNFR | TNF receptor superfamily member 1B |
TCMBANKGE008743 | OPRK1 | K-OR-1; KOP; KOR; KOR-1; KOR1; OPRK | opioid receptor kappa 1 |
TCMBANKGE001007 | NR1I2 | BXR; ONR1; PAR; PAR1; PAR2; PARq; PRR; PXR; SAR; SXR | nuclear receptor subfamily 1 group I member 2 |
TCMBANKGE004114 | CDKN3 | CDI1; CIP2; KAP; KAP1 | cyclin dependent kinase inhibitor 3 |
TCMBANKGE009478 | MYO5B | - | myosin VB |
TCMBANKGE000813 | DPP4 | ADABP; ADCP2; CD26; DPPIV; TP103 | dipeptidyl peptidase 4 |
TCMBANKGE014340 | MACF1 | ABP620; ACF7; LIS9; MACF; OFC4 | microtubule actin crosslinking factor 1 |
TCMBANKGE003331 | IL20 | IL-20; IL10D; ZCYTO10 | interleukin 20 |
TCMBANKGE001141 | PPARA | NR1C1; PPAR; PPARalpha; hPPAR | peroxisome proliferator activated receptor alpha |
TCMBANKGE000296 | PRDX2 | HEL-S-2a; NKEF-B; NKEFB; PRP; PRX2; PRXII; PTX1; TDPX1; TPX1; TSA | peroxiredoxin 2 |
TCMBANKGE014252 | IL15 | IL-15 | interleukin 15 |
TCMBANKGE006400 | PLG | - | plasminogen |
TCMBANKGE001176 | CAT | - | catalase |
TCMBANKGE000652 | STAT5B | STAT5 | signal transducer and activator of transcription 5B |
TCMBANKGE001697 | MMP1 | CLG; CLGN | matrix metallopeptidase 1 |
TCMBANKGE008702 | OPRM1 | LMOR; M-OR-1; MOP; MOR; MOR1; OPRM | opioid receptor mu 1 |
TCMBANKGE001018 | MUC2 | MLP; MUC-2; SMUC | mucin 2, oligomeric mucus/gel-forming |
TCMBANKGE009985 | P2RX4 | P2X4; P2X4R | purinergic receptor P2X 4 |
TCMBANKGE002867 | IL7 | IL-7 | interleukin 7 |
TCMBANKGE010043 | PPIF | CYP3; CyP-M; Cyp-D; CypD | peptidylprolyl isomerase F |
TCMBANKGE000417 | FDXR | ADR; ADXR; ANOA | ferredoxin reductase |
TCMBANKGE000428 | SERPINA1 | A1A; A1AT; AAT; PI; PI1; PRO2275; alpha1AT; nNIF | serpin family A member 1 |
TCMBANKGE000934 | GFAP | ALXDRD | glial fibrillary acidic protein |
TCMBANKGE000217 | P2RX7 | P2X7 | purinergic receptor P2X 7 |
TCMBANKGE001879 | STS | ARSC; ARSC1; ASC; ES; SSDD; XLI | steroid sulfatase |
TCMBANKGE000449 | CCK | - | cholecystokinin |
TCMBANKGE002622 | ZGLP1 | GATAD3; GLP-1; GLP1 | zinc finger GATA like protein 1 |
TCMBANKGE000997 | GCG | GLP-1; GLP1; GLP2; GRPP | glucagon |
TCMBANKGE013469 | FOXP2 | CAGH44; SPCH1; TNRC10 | forkhead box P2 |
TCMBANKGE003046 | AVP | ADH; ARVP; AVP-NPII; AVRP; VP | arginine vasopressin |
TCMBANKGE003493 | RC3H1 | RNF198; ROQUIN | ring finger and CCCH-type domains 1 |
TCMBANKGE000445 | CD44 | CDW44; CSPG8; ECMR-III; HCELL; HUTCH-I; IN; LHR; MC56; MDU2; MDU3; MIC4; Pgp1 | CD44 molecule (Indian blood group) |
TCMBANKGE000863 | GPBAR1 | BG37; GPCR19; GPR131; M-BAR; TGR5 | G protein-coupled bile acid receptor 1 |
TCMBANKGE002000 | CTLA4 | ALPS5; CD; CD152; CELIAC3; CTLA-4; GRD4; GSE; IDDM12 | cytotoxic T-lymphocyte associated protein 4 |
TCMBANKGE000729 | CASP1 | ICE; IL1BC; P45 | caspase 1 |
TCMBANKGE005959 | STX2 | EPIM; EPM; STX2A; STX2B; STX2C | syntaxin 2 |
TCMBANKGE013666 | PYCARD | ASC; CARD5; TMS; TMS-1; TMS1 | PYD and CARD domain containing |
TCMBANKGE014504 | ST14 | ARCI11; HAI; MT-SP1; MTSP1; PRSS14; SNC19; TADG15; TMPRSS14 | ST14 transmembrane serine protease matriptase |
TCMBANKGE002331 | LMNB1 | ADLD; LMN; LMN2; LMNB | lamin B1 |
TCMBANKGE001021 | MUC1 | ADMCKD; ADMCKD1; CA 15-3; CD227; EMA; H23AG; KL-6; MAM6; MCD; MCKD; MCKD1; MUC-1; MUC-1/SEC; MUC-1/X; MUC1/ZD; PEM; PEMT; PUM | mucin 1, cell surface associated |
TCMBANKGE008496 | NAPSA | KAP; Kdap; NAP1; NAPA; SNAPA | napsin A aspartic peptidase |
TCMBANKGE014557 | ANXA1 | ANX1; LPC1 | annexin A1 |
TCMBANKGE001012 | FOXP3 | AIID; DIETER; IPEX; JM2; PIDX; XPID | forkhead box P3 |
TCMBANKGE009543 | LTA | LT; TNFB; TNFSF1; TNLG1E | lymphotoxin alpha |
TCMBANKGE000290 | NQO1 | DHQU; DIA4; DTD; NMOR1; NMORI; QR1 | NAD(P)H quinone dehydrogenase 1 |
TCMBANKGE000908 | MUC5AC | MUC5; TBM; leB; mucin | mucin 5AC, oligomeric mucus/gel-forming |
TCMBANKGE000988 | HGF | DFNB39; F-TCF; HGFB; HPTA; SF | hepatocyte growth factor |
TCMBANKGE002550 | NPSR1 | ASRT2; GPR154; GPRA; NPSR; PGR14; VRR1 | neuropeptide S receptor 1 |
TCMBANKGE000007 | IL12B | CLMF; CLMF2; IL-12B; IMD28; IMD29; NKSF; NKSF2 | interleukin 12B |
TCMBANKGE000240 | IL17A | CTLA-8; CTLA8; IL-17; IL-17A; IL17 | interleukin 17A |
TCMBANKGE002243 | SLC9A3 | DIAR8; NHE-3; NHE3 | solute carrier family 9 member A3 |
TCMBANKGE010995 | GUSB | BG; MPS7 | glucuronidase beta |
TCMBANKGE000264 | ABCB1 | ABC20; CD243; CLCS; GP170; MDR1; P-GP; PGY1 | ATP binding cassette subfamily B member 1 |
TCMBANKGE001125 | IGF1 | IGF; IGF-I; IGFI; MGF | insulin like growth factor 1 |
TCMBANKGE005557 | LCN2 | 24p3; MSFI; NGAL; p25 | lipocalin 2 |
TCMBANKGE000586 | IL17F | CANDF6; IL-17F; ML-1; ML1 | interleukin 17F |
TCMBANKGE000228 | CRTC1 | MAML2; MECT1; Mam-2; TORC-1; TORC1; WAMTP1 | CREB regulated transcription coactivator 1 |
TCMBANKGE001193 | GDNF | ATF; ATF1; ATF2; HFB1-GDNF; HSCR3 | glial cell derived neurotrophic factor |
TCMBANKGE001096 | TLR4 | ARMD10; CD284; TLR-4; TOLL | toll like receptor 4 |
TCMBANKGE007264 | P2RX6 | P2RXL1; P2X6; P2XM | purinergic receptor P2X 6 |
TCMBANKGE001064 | GLP1R | GLP-1; GLP-1-R; GLP-1R | glucagon like peptide 1 receptor |
TCMBANKGE007547 | BRD2 | BRD2-IT1; D6S113E; FSH; FSRG1; NAT; O27.1.1; RING3; RNF3 | bromodomain containing 2 |
TCMBANKGE012621 | TFF3 | ITF; P1B; TFI | trefoil factor 3 |
TCMBANKGE000330 | HMOX1 | HMOX1D; HO-1; HSP32; bK286B10 | heme oxygenase 1 |
TCMBANKGE010005 | REG1B | PSPS2; REGH; REGI-BETA; REGL | regenerating family member 1 beta |
TCMBANKGE008183 | ACE | ACE1; CD143; DCP; DCP1 | angiotensin I converting enzyme |
TCMBANKGE012212 | CLDN3 | C7orf1; CPE-R2; CPETR2; HRVP1; RVP1 | claudin 3 |
TCMBANKGE000332 | CCL20 | CKb4; Exodus; LARC; MIP-3-alpha; MIP-3a; MIP3A; SCYA20; ST38 | C-C motif chemokine ligand 20 |
TCMBANKGE007417 | HSP90B1 | ECGP; GP96; GRP94; HEL-S-125m; HEL35; TRA1 | heat shock protein 90 beta family member 1 |
TCMBANKGE012031 | RAB8A | MEL; RAB8 | RAB8A, member RAS oncogene family |
TCMBANKGE007886 | HLA-G | MHC-G | major histocompatibility complex, class I, G |
TCMBANKGE003625 | SLC6A4 | 5-HTT; 5-HTTLPR; 5HTT; HTT; OCD1; SERT; SERT1; hSERT | solute carrier family 6 member 4 |
TCMBANKGE014136 | LTF | GIG12; HEL110; HLF2; LF | lactotransferrin |
TCMBANKGE001205 | DDIT3 | AltDDIT3; C/EBPzeta; CEBPZ; CHOP; CHOP-10; CHOP10; GADD153 | DNA damage inducible transcript 3 |
TCMBANKGE001080 | AHR | RP85; bHLHe76 | aryl hydrocarbon receptor |
TCMBANKGE011142 | USH1C | AIE-75; DFNB18; DFNB18A; NY-CO-37; NY-CO-38; PDZ-45; PDZ-73; PDZ-73/NY-CO-38; PDZ73; PDZD7C; ush1cpst | USH1 protein network component harmonin |
TCMBANKGE005378 | KRT20 | CD20; CK-20; CK20; K20; KRT21 | keratin 20 |
TCMBANKGE005424 | CDCA7 | ICF3; JPO1 | cell division cycle associated 7 |
TCMBANKGE002832 | IL17B | IL-17B; IL-20; NIRF; ZCYTO7 | interleukin 17B |
TCMBANKGE000644 | TNFRSF1A | CD120a; FPF; TBP1; TNF-R; TNF-R-I; TNF-R55; TNFAR; TNFR1; TNFR55; TNFR60; p55; p55-R; p60 | TNF receptor superfamily member 1A |
TCMBANKGE005497 | SAMD9 | C7orf5; DRIF1; MIRAGE; NFTC; OEF1; OEF2 | sterile alpha motif domain containing 9 |
TCMBANKGE005458 | MT3 | GIF; GIFB; GRIF; ZnMT3 | metallothionein 3 |
TCMBANKGE000954 | ABCB11 | ABC16; BRIC2; BSEP; PFIC-2; PFIC2; PGY4; SPGP | ATP binding cassette subfamily B member 11 |
TCMBANKGE000013 | G6PC | G6PC1; G6PT; G6Pase; GSD1; GSD1a | glucose-6-phosphatase catalytic subunit |
TCMBANKGE001168 | RIPK1 | AIEFL; IMD57; RIP; RIP-1; RIP1 | receptor interacting serine/threonine kinase 1 |
TCMBANKGE000764 | TRPV1 | VR1 | transient receptor potential cation channel subfamily V member 1 |
TCMBANKGE001029 | IL13 | IL-13; P600 | interleukin 13 |
TCMBANKGE010852 | DGAT1 | ARAT; ARGP1; DGAT; DIAR7 | diacylglycerol O-acyltransferase 1 |
TCMBANKGE007788 | MATK | CHK; CTK; HHYLTK; HYL; HYLTK; Lsk | megakaryocyte-associated tyrosine kinase |
TCMBANKGE004720 | P2RX5 | LRH-1; P2X5; P2X5R | purinergic receptor P2X 5 |
TCMBANKGE005064 | ABHD5 | CGI58; IECN2; NCIE2 | abhydrolase domain containing 5, lysophosphatidic acid acyltransferase |
TCMBANKGE000315 | IL4 | BCGF-1; BCGF1; BSF-1; BSF1; IL-4 | interleukin 4 |